Status:
COMPLETED
Retinyl Palmitate-loaded Ethosomes in Acne Vulgaris
Lead Sponsor:
Assiut University
Conditions:
Facial Acne Vulgaris
Eligibility:
All Genders
12-40 years
Phase:
PHASE2
Brief Summary
Acne is a chronic inflammatory dermatosis of the pilosebaceous unit. Topical treatment is the first choice in mild and moderate cases of acne, especially topical retinoids. Although topical retinoids ...
Eligibility Criteria
Inclusion
- Patients with facial mild to moderate acne vulgaris
- Patients aged 12-40 years old
Exclusion
- Pregnant females
- Patients with skin condition of the face such as rosacea, perioral dermatitis, atopic or seborrheic dermatitis or psoriasis.
- Patients with known hypersensitivity to preparations containing retinoid.
- Patients who take any other cocomitant systemic or topical medications for acne vulgaris
Key Trial Info
Start Date :
January 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04080869
Start Date
January 6 2020
End Date
November 30 2020
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospital
Asyut, Egypt